Rhythm Pharmaceuticals buy Canaccord Genuity Group Inc.
Start price
02.03.26
/
50%
€81.50
Target price
02.03.27
€118.79
Performance (%)
-4.91%
Price
16.06.26
?
Summary
This prediction is currently active. With a performance of -4.91%, the BUY prediction for Rhythm Pharmaceuticals by Canaccord_Genuity_Gr is down slightly. This prediction currently runs until 02.03.27. The prediction end date can be changed by Canaccord_Genuity_Gr at any time. Canaccord_Genuity_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Rhythm Pharmaceuticals | 5.369% | 5.369% |
| iShares Core DAX® | 1,11 % | 3,98 % |
| iShares Nasdaq 100 | 3,27 % | 5,22 % |
| iShares Nikkei 225® | 5,78 % | 11,58 % |
| iShares S&P 500 | 1,64 % | 2,44 % |
Comments by Canaccord_Genuity_Gr for this prediction
In the thread Rhythm Pharmaceuticals diskutieren
Rhythm Pharmaceuticals (RYTM) had its price target lowered by Canaccord Genuity Group Inc. from $141.00 to $140.00. They now have a "buy" rating on the stock.
Ratings data for RYTM provided by MarketBeat
Stopped prediction by Canaccord_Genuity_Gr for Rhythm Pharmaceuticals
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€77.00
16.06.26
16.06.26
€130.39
16.06.27
16.06.27
0.65%
16.06.26
16.06.26
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€21.20
02.03.23
02.03.23
€52.93
02.03.24
02.03.24
85.85%
03.03.24
03.03.24